ophthalmology, preclinical research, clinical trial, phase 1 to phase 4, medico-marketing survey, pharmacology, pharmacokinetics, efficacy, tolerance, proof of concept, pilot, early testing, histology, bioanalysis, biomarker, formulation, GLP, GCP, GCLP

Iris Pharma is a world-leading Contract Research Organization (CRO) offering ophthalmologic drug and device development services. From animal proof of concept and in vivo regulatory development through to clinical trials and marketing surveys, Iris Pharma staff have excellent knowledge and expertise in each step of the drug development process.
Iris Pharma works hand-in-hand with customers and has helped bring 70 ocular drugs and medical devices to international markets to date.
Wherever you stand with your project and wherever you want to go, Iris Pharma will be able to guide you through the appropriate steps by bringing personalized advice and offering programs and study designs that will perfectly suit your needs (therapeutic value assessment, full preclinical regulatory package, à la carte studies…).